Altimmune, Inc.
ALT
$3.33
-$0.04-1.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.57% | -0.93% | 7.33% | 18.94% | 13.42% |
| Total Depreciation and Amortization | -23.26% | -33.75% | -52.94% | -62.70% | 147.78% |
| Total Amortization of Deferred Charges | 584.48% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.34% | 40.15% | 30.48% | -47.53% | -54.89% |
| Change in Net Operating Assets | 120.66% | 765.91% | 50.78% | 97.46% | -159.67% |
| Cash from Operations | 6.21% | 10.82% | 15.42% | 15.06% | -14.11% |
| Capital Expenditure | -440.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -509.17% | -2,271.53% | -366.65% | 20.62% | 336.98% |
| Cash from Investing | -509.26% | -2,272.06% | -366.68% | 20.60% | 336.96% |
| Total Debt Issued | 37.02% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 370.62% | 380.74% | 1,499.66% | 66.73% | 12.70% |
| Repurchase of Common Stock | -5.26% | 22.41% | 17.29% | 23.16% | 22.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -161.07% | -962.81% | -- | -- | -- |
| Cash from Financing | 323.95% | 465.45% | 1,959.36% | 86.76% | 32.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.33% | 262.34% | 106.96% | 153.74% | 378.56% |